IBS-C Drugs Market Report

Global IBS-C Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 21, 2020
  • PAGES：222
  • REPORT CODE：GMM574332
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The IBS-C Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The research provides insights for the global IBS-C Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the IBS-C Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global IBS-C Drugs Market Segmentations:

    By Players:

    • Sucampo Pharmaceuticals

    • Salix Pharmaceuticals Ltd

    • Actavis Nordic A/S

    • The Menarini Group

    • Bama-Geve, SLU

    • Astellas Pharmaceuticals

    • Astrazeneca Plc

    • Ferring BV

    • Ironwood Pharmaceuticals, Inc

    • Catalent Pharmaceuticals Solutions

    • Ardelyx, Inc

    • Prometheus Laboratories Inc

    • Novartis Pharma Ag

    • Teva Pharmaceutical Industries

    • Abbott Laboratories

    • Nestle

    • Yuhan Corp

    • Albireo Pharma Inc

    • Synergy Pharmaceuticals

    • Synthetic Biologics, Inc

    By Types:

    • Linaclotide

    • Lubiprostone

    • Osmotic Laxatives

    • Stimulant Laxatives

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of IBS-C Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global IBS-C Drugs Market Size and Growth Rate of Linaclotide from 2014 to 2026

      • 1.3.2 Global IBS-C Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

      • 1.3.3 Global IBS-C Drugs Market Size and Growth Rate of Osmotic Laxatives from 2014 to 2026

      • 1.3.4 Global IBS-C Drugs Market Size and Growth Rate of Stimulant Laxatives from 2014 to 2026

      • 1.3.5 Global IBS-C Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global IBS-C Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.2 Global IBS-C Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.3 Global IBS-C Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina IBS-C Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of IBS-C Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of IBS-C Drugs by Major Types

      • 3.4.1 IBS-C Drugs Market Size and Growth Rate of Linaclotide

      • 3.4.2 IBS-C Drugs Market Size and Growth Rate of Lubiprostone

      • 3.4.3 IBS-C Drugs Market Size and Growth Rate of Osmotic Laxatives

      • 3.4.4 IBS-C Drugs Market Size and Growth Rate of Stimulant Laxatives

      • 3.4.5 IBS-C Drugs Market Size and Growth Rate of Others

    4 Segmentation of IBS-C Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of IBS-C Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of IBS-C Drugs in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of IBS-C Drugs in Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of IBS-C Drugs in Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Global IBS-C Drugs Production Analysis by Major Regions

    • 5.2 Global IBS-C Drugs Consumption Analysis by Major Regions

    • 5.3 Global IBS-C Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America IBS-C Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe IBS-C Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific IBS-C Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa IBS-C Drugs Production, Import, Consumption and Export Analysis

    6 Product Commodity of IBS-C Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in IBS-C Drugs market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in IBS-C Drugs market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in IBS-C Drugs market from 2014 to 2019

    • 6.2 Top 5 Import Countries in IBS-C Drugs market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in IBS-C Drugs market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in IBS-C Drugs market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America IBS-C Drugs Landscape Analysis

    • 7.1 North America IBS-C Drugs Landscape Analysis by Major Types

    • 7.2 North America IBS-C Drugs Landscape Analysis by Major End-Users

    • 7.3 North America IBS-C Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States IBS-C Drugs Market Volume and Growth Rate

      • 7.3.2 Canada IBS-C Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico IBS-C Drugs Market Volume and Growth Rate

    8 Europe IBS-C Drugs Landscape Analysis

    • 8.1 Europe IBS-C Drugs Landscape Analysis by Major Types

    • 8.2 Europe IBS-C Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe IBS-C Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany IBS-C Drugs Market Volume and Growth Rate

      • 8.3.2 UK IBS-C Drugs Market Volume and Growth Rate

      • 8.3.3 France IBS-C Drugs Market Volume and Growth Rate

      • 8.3.4 Italy IBS-C Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries IBS-C Drugs Market Volume and Growth Rate

      • 8.3.6 Spain IBS-C Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium IBS-C Drugs Market Volume and Growth Rate

      • 8.3.8 Poland IBS-C Drugs Market Volume and Growth Rate

      • 8.3.9 Russia IBS-C Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey IBS-C Drugs Market Volume and Growth Rate

    9 Asia Pacific IBS-C Drugs Landscape Analysis

    • 9.1 Asia Pacific IBS-C Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific IBS-C Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific IBS-C Drugs Landscape Analysis by Major Countries

      • 9.3.1 China IBS-C Drugs Market Volume and Growth Rate

      • 9.3.2 Japan IBS-C Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand IBS-C Drugs Market Volume and Growth Rate

      • 9.3.4 India IBS-C Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries IBS-C Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea IBS-C Drugs Market Volume and Growth Rate

    10 Latin America, Middle East & Africa IBS-C Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa IBS-C Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa IBS-C Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa IBS-C Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries IBS-C Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil IBS-C Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria IBS-C Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa IBS-C Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina IBS-C Drugs Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Sucampo Pharmaceuticals

      • 11.1.1 Sucampo Pharmaceuticals Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Salix Pharmaceuticals Ltd

      • 11.2.1 Salix Pharmaceuticals Ltd Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Actavis Nordic A/S

      • 11.3.1 Actavis Nordic A/S Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 The Menarini Group

      • 11.4.1 The Menarini Group Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Bama-Geve, SLU

      • 11.5.1 Bama-Geve, SLU Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Astellas Pharmaceuticals

      • 11.6.1 Astellas Pharmaceuticals Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Astrazeneca Plc

      • 11.7.1 Astrazeneca Plc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Ferring BV

      • 11.8.1 Ferring BV Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Ironwood Pharmaceuticals, Inc

      • 11.9.1 Ironwood Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Catalent Pharmaceuticals Solutions

      • 11.10.1 Catalent Pharmaceuticals Solutions Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Ardelyx, Inc

      • 11.11.1 Ardelyx, Inc Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Prometheus Laboratories Inc

      • 11.12.1 Prometheus Laboratories Inc Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Novartis Pharma Ag

      • 11.13.1 Novartis Pharma Ag Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Teva Pharmaceutical Industries

      • 11.14.1 Teva Pharmaceutical Industries Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Abbott Laboratories

      • 11.15.1 Abbott Laboratories Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Nestle

      • 11.16.1 Nestle Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Yuhan Corp

      • 11.17.1 Yuhan Corp Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Albireo Pharma Inc

      • 11.18.1 Albireo Pharma Inc Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Synergy Pharmaceuticals

      • 11.19.1 Synergy Pharmaceuticals Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Synthetic Biologics, Inc

      • 11.20.1 Synthetic Biologics, Inc Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 114 Figures and 131 Tables)

    • Figure Product Picture

    • Figure IBS-C Drugs Market Size and Growth Rate of Linaclotide from 2014 to 2026

    • Figure IBS-C Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • Figure IBS-C Drugs Market Size and Growth Rate of Osmotic Laxatives from 2014 to 2026

    • Figure IBS-C Drugs Market Size and Growth Rate of Stimulant Laxatives from 2014 to 2026

    • Figure IBS-C Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina IBS-C Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of IBS-C Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of IBS-C Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of IBS-C Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of IBS-C Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Linaclotide

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Osmotic Laxatives

    • Figure Market Size and Growth Rate of Stimulant Laxatives

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of IBS-C Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of IBS-C Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Global IBS-C Drugs Production by Major Regions

    • Table Global IBS-C Drugs Production Share by Major Regions

    • Figure Global IBS-C Drugs Production Share by Major Regions in 2014

    • Figure Global IBS-C Drugs Production Share by Major Regions in 2018

    • Figure Global IBS-C Drugs Production Share by Major Regions in 2026

    • Table Global IBS-C Drugs Consumption by Major Regions

    • Table Global IBS-C Drugs Consumption Share by Major Regions

    • Figure Global IBS-C Drugs Consumption Share by Major Regions in 2014

    • Figure Global IBS-C Drugs Consumption Share by Major Regions in 2018

    • Figure Global IBS-C Drugs Consumption Share by Major Regions in 2026

    • Table North America IBS-C Drugs Production, Import, Consumption and Export Analysis

    • Table Europe IBS-C Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific IBS-C Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa IBS-C Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in IBS-C Drugs market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in IBS-C Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in IBS-C Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in IBS-C Drugs market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America IBS-C Drugs Consumption by Types from 2014 to 2026

    • Table North America IBS-C Drugs Consumption Share by Types from 2014 to 2026

    • Figure North America IBS-C Drugs Consumption Share by Types in 2014

    • Figure North America IBS-C Drugs Consumption Share by Types in 2018

    • Figure North America IBS-C Drugs Consumption Share by Types in 2026

    • Table North America IBS-C Drugs Consumption by End-Users from 2014 to 2026

    • Table North America IBS-C Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure North America IBS-C Drugs Consumption Share by End-Users in 2014

    • Figure North America IBS-C Drugs Consumption Share by End-Users in 2018

    • Figure North America IBS-C Drugs Consumption Share by End-Users in 2026

    • Table North America IBS-C Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America IBS-C Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America IBS-C Drugs Consumption Share by Major Countries in 2014

    • Figure North America IBS-C Drugs Consumption Share by Major Countries in 2018

    • Figure North America IBS-C Drugs Consumption Share by Major Countries in 2026

    • Figure United States IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe IBS-C Drugs Consumption by Types from 2014 to 2026

    • Table Europe IBS-C Drugs Consumption Share by Types from 2014 to 2026

    • Figure Europe IBS-C Drugs Consumption Share by Types in 2014

    • Figure Europe IBS-C Drugs Consumption Share by Types in 2018

    • Figure Europe IBS-C Drugs Consumption Share by Types in 2026

    • Table Europe IBS-C Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe IBS-C Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Europe IBS-C Drugs Consumption Share by End-Users in 2014

    • Figure Europe IBS-C Drugs Consumption Share by End-Users in 2018

    • Figure Europe IBS-C Drugs Consumption Share by End-Users in 2026

    • Table Europe IBS-C Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe IBS-C Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe IBS-C Drugs Consumption Share by Major Countries in 2014

    • Figure Europe IBS-C Drugs Consumption Share by Major Countries in 2018

    • Figure Europe IBS-C Drugs Consumption Share by Major Countries in 2026

    • Figure Germany IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific IBS-C Drugs Consumption by Types from 2014 to 2026

    • Table Asia Pacific IBS-C Drugs Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific IBS-C Drugs Consumption Share by Types in 2014

    • Figure Asia Pacific IBS-C Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific IBS-C Drugs Consumption Share by Types in 2026

    • Table Asia Pacific IBS-C Drugs Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific IBS-C Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific IBS-C Drugs Consumption Share by End-Users in 2014

    • Figure Asia Pacific IBS-C Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific IBS-C Drugs Consumption Share by End-Users in 2026

    • Table Asia Pacific IBS-C Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific IBS-C Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific IBS-C Drugs Consumption Share by Major Countries in 2014

    • Figure Asia Pacific IBS-C Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific IBS-C Drugs Consumption Share by Major Countries in 2026

    • Figure China IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandIBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS-C Drugs Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa IBS-C Drugs Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS-C Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa IBS-C Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa IBS-C Drugs Consumption Share by Major Countries in 2026

    • Figure GCC Countries IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina IBS-C Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals

    • Table Product and Service Introduction of Sucampo Pharmaceuticals

    • Table Company Profile and Development Status of Salix Pharmaceuticals Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals Ltd

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals Ltd

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals Ltd

    • Table Product and Service Introduction of Salix Pharmaceuticals Ltd

    • Table Company Profile and Development Status of Actavis Nordic A/S

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Nordic A/S

    • Figure Sales and Growth Rate Analysis of Actavis Nordic A/S

    • Figure Revenue and Market Share Analysis of Actavis Nordic A/S

    • Table Product and Service Introduction of Actavis Nordic A/S

    • Table Company Profile and Development Status of The Menarini Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Menarini Group

    • Figure Sales and Growth Rate Analysis of The Menarini Group

    • Figure Revenue and Market Share Analysis of The Menarini Group

    • Table Product and Service Introduction of The Menarini Group

    • Table Company Profile and Development Status of Bama-Geve, SLU

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bama-Geve, SLU

    • Figure Sales and Growth Rate Analysis of Bama-Geve, SLU

    • Figure Revenue and Market Share Analysis of Bama-Geve, SLU

    • Table Product and Service Introduction of Bama-Geve, SLU

    • Table Company Profile and Development Status of Astellas Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Astellas Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Astellas Pharmaceuticals

    • Table Product and Service Introduction of Astellas Pharmaceuticals

    • Table Company Profile and Development Status of Astrazeneca Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca Plc

    • Figure Sales and Growth Rate Analysis of Astrazeneca Plc

    • Figure Revenue and Market Share Analysis of Astrazeneca Plc

    • Table Product and Service Introduction of Astrazeneca Plc

    • Table Company Profile and Development Status of Ferring BV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring BV

    • Figure Sales and Growth Rate Analysis of Ferring BV

    • Figure Revenue and Market Share Analysis of Ferring BV

    • Table Product and Service Introduction of Ferring BV

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals, Inc

    • Table Product and Service Introduction of Ironwood Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Catalent Pharmaceuticals Solutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalent Pharmaceuticals Solutions

    • Figure Sales and Growth Rate Analysis of Catalent Pharmaceuticals Solutions

    • Figure Revenue and Market Share Analysis of Catalent Pharmaceuticals Solutions

    • Table Product and Service Introduction of Catalent Pharmaceuticals Solutions

    • Table Company Profile and Development Status of Ardelyx, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ardelyx, Inc

    • Figure Sales and Growth Rate Analysis of Ardelyx, Inc

    • Figure Revenue and Market Share Analysis of Ardelyx, Inc

    • Table Product and Service Introduction of Ardelyx, Inc

    • Table Company Profile and Development Status of Prometheus Laboratories Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Prometheus Laboratories Inc

    • Figure Sales and Growth Rate Analysis of Prometheus Laboratories Inc

    • Figure Revenue and Market Share Analysis of Prometheus Laboratories Inc

    • Table Product and Service Introduction of Prometheus Laboratories Inc

    • Table Company Profile and Development Status of Novartis Pharma Ag

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharma Ag

    • Figure Sales and Growth Rate Analysis of Novartis Pharma Ag

    • Figure Revenue and Market Share Analysis of Novartis Pharma Ag

    • Table Product and Service Introduction of Novartis Pharma Ag

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Nestle

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nestle

    • Figure Sales and Growth Rate Analysis of Nestle

    • Figure Revenue and Market Share Analysis of Nestle

    • Table Product and Service Introduction of Nestle

    • Table Company Profile and Development Status of Yuhan Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yuhan Corp

    • Figure Sales and Growth Rate Analysis of Yuhan Corp

    • Figure Revenue and Market Share Analysis of Yuhan Corp

    • Table Product and Service Introduction of Yuhan Corp

    • Table Company Profile and Development Status of Albireo Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Albireo Pharma Inc

    • Figure Sales and Growth Rate Analysis of Albireo Pharma Inc

    • Figure Revenue and Market Share Analysis of Albireo Pharma Inc

    • Table Product and Service Introduction of Albireo Pharma Inc

    • Table Company Profile and Development Status of Synergy Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals

    • Table Product and Service Introduction of Synergy Pharmaceuticals

    • Table Company Profile and Development Status of Synthetic Biologics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthetic Biologics, Inc

    • Figure Sales and Growth Rate Analysis of Synthetic Biologics, Inc

    • Figure Revenue and Market Share Analysis of Synthetic Biologics, Inc

    • Table Product and Service Introduction of Synthetic Biologics, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US